FEDERAL STREET STRATEGIES, LLC

Lobbying for ABBVIE, INC. · Biopharmaceutical Research & Development Company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Health Issues

Patient Access to drug treatment therapies; and drug cost and drug pricing reform. Oversight of the pharmaceutical industry and drug pricing. Policies as they relate to PBMs Issues related to the FY2026 budget and appropriations process

Medicare/Medicaid

Medicare Part D policies. Monitoring Policies related to the 340b program. Issues related to the implementation of the Inflation Reduction Act Issues related to the FY2026 budget and appropriations process

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.